Silodosin
- Level
- Commodity
- Parent
- 51262100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51262102This classification denotes an alpha-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CUZ39LUY82. European Medicines Agency schedules Silodosin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23152. Silodosin generally arises in the molecular formula C25H32F3N3O4. The term SILODOSIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., no. 1.2002, list 47.) Most nations schedule silodosin under HS 29339990 and SITC 51577. As of Q4 2014, SILODOSIN remains the US FDA Preferred Term for this commodity. Silodosin bears US NLM identifiers UMLS ID C1870115 and NCI Concept Code C81372. SMILES: FC(F)(F)COC1C(OCCNC(CC2CC3C(N(CC3)CCCO)C(C2)C(=O)N)C)CCCC1.
Same parent
Under 51262100 · 4Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.